Hellman Jordan Management CO Inc Moderna, Inc. Transaction History
Hellman Jordan Management CO Inc
- $58.9 Million
- Q4 2022
A detailed history of Hellman Jordan Management CO Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Hellman Jordan Management CO Inc holds 6,073 shares of MRNA stock, worth $323,630. This represents 1.85% of its overall portfolio holdings.
Number of Shares
6,073
Previous 5,557
9.29%
Holding current value
$323,630
Previous $657,000
66.06%
% of portfolio
1.85%
Previous 1.14%
Shares
14 transactions
Others Institutions Holding MRNA
# of Institutions
1,030Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO42.5MShares$2.26 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.11 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.36 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$801 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$385 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $20.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...